Treace Medical Concepts, Inc. (TMCI) News
Follow Treace Medical Concepts, Inc. (TMCI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Treace Medical Concepts Reports Q3 2026 Results, Updates Revenue Guidance
Treace reported a net loss of $12.6 million, or $0.19 per share, versus $16.3 million, or $0.26 per share, a year earlier. Adjusted EBITDA was $0.3 million, compared with $(2.6) million. The company narrowed its 2026 rev
EQUITY | Nov 06, 2026, 02:04 PM UTC
M
Treace Medical Q3 Revenue Falls but Slightly Beats Expectations
EQUITY | Nov 06, 2026, 12:17 PM UTC
M
Treace Medical reports Q3 EPS of USD -0.19
Treace Medical reported Q3 gross profit of USD 38.35 million.
EARNINGS | Nov 06, 2026, 12:08 PM UTC
M
Treace Medical Concepts Reports Third-Quarter 2026 Financial Results
Treace Medical Concepts said procedure volume grew by double digits in the third quarter.
EQUITY | Nov 06, 2026, 12:07 PM UTC
L
TMCI - Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting
TMCI - Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting
NEWS | Sep 15, 2026, 09:06 PM UTC
L
Treace Medical Concepts Raises FY2026 Sales Guidance from $202.000M-$212.000M to $204.000M-$212.000M vs $206.220M Est
Treace Medical Concepts (NASDAQ: TMCI ) raises FY2026 sales outlook from $202.000 million-$212.000 million to $204.000 million-$212.000 million vs $206.220 million estimate.
EARNINGS | Aug 07, 2026, 11:05 AM UTC